Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Samrat Pharmachem Ltd

Your Vote -

Buy

66.67%

Hold

16.67%

Sell

16.67%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Samrat Pharmachem Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating

    3 Jun 2025, 3:53PM Credit Rating
  • Samrat Pharma posts Q4 net loss of Rs 0.40 cr

    31 May 2025, 10:03AM The company reported standalone net loss during the quarter stood at Rs 0.40 crore compared to net profit of Rs 1.40 crore in the previous year quarte
  • Samrat Pharma - Audited Financial Results For The Year Ended March 31, 2025

    30 May 2025, 8:54PM Audited Financial Results for the year ended March 31, 2025\r\nRecommendation of Dividend @ 10% on paid up capital of the company
  • Samrat Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held Today

    30 May 2025, 8:48PM Outcome of Board Meeting held today
  • Samrat Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:11PM As of March 2025, 49.09% is owned by Indian Promoters and 50.91% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2025, 3:36PM Certificate u/r 74(5) for the quarter ended March 31, 2025
  • Samrat Pharma - Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financ

    26 Mar 2025, 1:03PM Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider a

Key fundamentals

Evaluate the intrinsic value of Samrat Pharmachem Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 81.7151 73.4517 81.8026 54.3414 38.4305
Liabilities 81.7151 73.4517 81.8026 54.3414 38.4305
Equity 3.0897 3.0897 3.0897 3.0897 3.0897
Gross Profit 10.2415 2.4695 23.9274 24.3433 8.6683
Net Profit 7.1122 2.1626 16.6305 17.1849 5.3331
Cash From Operating Activities -10.0914 9.412 -9.4368 17.7819 4.8343
NPM(%) 2.48 0.76 5.35 7.74 2.97
Revenue 285.8605 281.5812 310.6459 221.8117 179.0177
Expenses 275.619 279.1117 286.7185 197.4684 170.3494
ROE(%) 9.9 3.01 23.16 23.93 7.42

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Samrat Pharmachem Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 859.90 1.12 28.38 200.41 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.27 -2.54 205.89 730.26 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 26.00 1.13 0.00 1516.27 -39.50 0.00
Astec Lifesciences Ltd 806.15 -0.38 0.00 688.57 -687.10 0.00

Company Info

Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.

Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.

Read More

Parent Organisation

Samrat Pharmachem Ltd.

Founded

16/06/1992

Managing Director

Mr.Lalit Mehta

NSE Symbol

FAQ

The current price of Samrat Pharmachem Ltd is

The 52-week high for Samrat Pharmachem Ltd is

The market capitalization of Samrat Pharmachem Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Samrat Pharmachem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Samrat Pharmachem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Samrat Pharmachem Ltd shares.

The CEO of Samrat Pharmachem Ltd is Mr.Lalit Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT